Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted cellular immunotherapy with bifunctional antibodies.

H Nelson1

  • 1Department of Surgery, Mayo Foundation, Rochester, Minnesota 55905.

Cancer Cells (Cold Spring Harbor, N.Y. : 1989)
|May 1, 1991
PubMed
Summary

Bifunctional antibodies link T lymphocytes to tumor cells, redirecting the immune system to fight cancer. This approach enhances T cell-mediated tumor cell lysis and shows promise in preclinical models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • T lymphocytes are crucial for adaptive immunity and tumor surveillance.
  • Cancer cells often evade immune detection and destruction.
  • Bifunctional antibodies offer a strategy to enhance anti-tumor immune responses.

Purpose of the Study:

  • To investigate the potential of bifunctional antibodies in redirecting T lymphocytes for tumor cell lysis.
  • To explore the efficacy of bifunctional antibodies against various human tumors.
  • To identify areas for improvement in bifunctional antibody preparation and tumor targeting.

Main Methods:

  • Conjugation of antitumor cell antibodies with antilymphocyte antibodies to create bifunctional reagents.
  • In vitro studies assessing T lymphocyte-mediated lysis of tumor cells.
  • In vivo studies using human tumor xenografts in animal models to evaluate anti-tumor activity.

Main Results:

  • Bifunctional antibodies successfully redirected T lymphocytes to lyse human tumor cells in vitro.
  • Demonstrated neutralization of human tumor xenografts in vivo.
  • Studies explored diverse effector cell populations and tumor targets.

Conclusions:

  • Bifunctional antibodies represent a promising strategy for cancer immunotherapy by retargeting T lymphocytes.
  • Further research is needed to optimize antibody reagent preparation and cellular trafficking to tumors for enhanced clinical efficacy.

Related Experiment Videos